171 related articles for article (PubMed ID: 19694612)
1. Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.
Arias JL; Reddy LH; Couvreur P
J Drug Target; 2009 Sep; 17(8):586-98. PubMed ID: 19694612
[TBL] [Abstract][Full Text] [Related]
2. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.
Arias JL; Reddy LH; Couvreur P
Biomacromolecules; 2011 Jan; 12(1):97-104. PubMed ID: 21117615
[TBL] [Abstract][Full Text] [Related]
3. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
[TBL] [Abstract][Full Text] [Related]
4. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
5. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.
Martín-Banderas L; Sáez-Fernández E; Holgado MÁ; Durán-Lobato MM; Prados JC; Melguizo C; Arias JL
Int J Pharm; 2013 Feb; 443(1-2):103-9. PubMed ID: 23299085
[TBL] [Abstract][Full Text] [Related]
7. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles.
Arias JL; Ruiz M; Gallardo V; Delgado AV
J Control Release; 2008 Jan; 125(1):50-8. PubMed ID: 17949844
[TBL] [Abstract][Full Text] [Related]
8. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.
Ortiz R; Cabeza L; Arias JL; Melguizo C; Álvarez PJ; Vélez C; Clares B; Áranega A; Prados J
AAPS J; 2015 Jul; 17(4):918-29. PubMed ID: 25894746
[TBL] [Abstract][Full Text] [Related]
9. Acid-Triggered Release of Native Gemcitabine Conjugated in Polyketal Nanoparticles for Enhanced Anticancer Therapy.
Zhong H; Mu J; Du Y; Xu Z; Xu Y; Yu N; Zhang S; Guo S
Biomacromolecules; 2020 Feb; 21(2):803-814. PubMed ID: 31995366
[TBL] [Abstract][Full Text] [Related]
10. Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.
Galmarini CM; Warren G; Senanayake MT; Vinogradov SV
Int J Pharm; 2010 Aug; 395(1-2):281-9. PubMed ID: 20580798
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
13. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres.
Arias JL; Gallardo V; Ruiz MA; Delgado AV
Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
[TBL] [Abstract][Full Text] [Related]
15. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
Arias JL; Ruiz MA; López-Viota M; Delgado AV
Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
[TBL] [Abstract][Full Text] [Related]
16. Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.
Kim DH; Guo Y; Zhang Z; Procissi D; Nicolai J; Omary RA; Larson AC
Adv Healthc Mater; 2014 May; 3(5):714-24. PubMed ID: 24574255
[TBL] [Abstract][Full Text] [Related]
17. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
Chitkara D; Kumar N
Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
19. Role of chitosan nanoparticles in the oral absorption of Gemcitabine.
Derakhshandeh K; Fathi S
Int J Pharm; 2012 Nov; 437(1-2):172-7. PubMed ID: 22909993
[TBL] [Abstract][Full Text] [Related]
20. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]